Verastem, Inc.

For the period ended Dec 31, 2024. Filed Mar 20, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 20, 2025

VSTM$8.70+3.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except per share amounts)


· · · · · ·
· · December 31, ·
· 2024 · 2023
Assets
Current assets:
Cash and cash equivalents	$88,818	$77,909
Short-term investments	—	59,220
Grant receivable	200	—
Prepaid expenses and other current assets	5,943	6,553
Total current assets	94,961	143,682
Property and equipment, net	32	37
Right-of-use asset, net	1,405	1,171
Restricted cash	241	241
Other assets	4,899	4,587
Total assets	$101,538	$149,718
Liabilities, convertible preferred stock and stockholders’ equity
Current liabilities:
Accounts payable	$4,026	$7,184
Accrued expenses	25,952	17,928
Deferred liabilities	—	327
Lease liability, short-term	995	941
Total current liabilities	30,973	26,380
Non-current liabilities:
Long-term debt	40,724	40,086
Lease liability, long-term	535	530
Preferred stock tranche liability	—	4,189
Warrant liability	58,199	—
Total liabilities	130,431	71,185
Convertible preferred stock:
Series B Convertible Preferred Stock, $0.0001 par value; 944 shares and 2,144 shares designated at December 31, 2024 and December 31, 2023, respectively; 0 shares and 1,200 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	—	21,159
Stockholders’ equity:
Preferred Stock, $0.0001 par value; 5,000 shares authorized:
Series A Convertible Preferred Stock, $0.0001 par value; 1,000 shares designated, 1,000 shares issued and outstanding at December 31, 2024 and December 31, 2023	—	—
Common stock, $0.0001 par value; 300,000 shares authorized, 44,784 and 25,281 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	4	3
Additional paid-in capital	926,630	882,248
Accumulated other comprehensive income	—	13
Accumulated deficit	(955,527)	(824,890)
Total stockholders’ (deficit) equity	(28,893)	57,374
Total liabilities, convertible preferred stock and stockholders’ (deficit) equity	$101,538	$149,718

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.